28
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Systemic Lupus Erythematosus and Related Diseases

&
Pages 301-304 | Published online: 07 Jul 2009

References

  • Hahn, B.H. (1998) "Mechanism of disease: antibodies to DNA", N. Engl. J. Med. 338, 1359–1368.
  • Wakeland, E.K., Wandstrat, A.E., Liu, K. and Morel, L. (1999) "Genetic dissection of systemic lupus erythematosus", Curr. Opin. Immunol. 11, 701–707.
  • Pisetsky, D.S. (2000) "Anti-DNA and autoantibodies", Curr. Opin. Rheumatol. 12, 364–368.
  • Pisetsky, D.S. (2001) In: Klippel, J.H., Crofford, L.J., Stone, J.H. and Weyand, CM., eds, Systemic lupus erythematosus A. Epidemiology, Pathology, and Pathogenesis Primer on the Rheumatic Diseases, 12th ed. (Arthritis Foundation, Atlanta, GA) pp 329–335.
  • Buyon, J.P. (2001) In: Klippel, J.H., Crofford, L.J., Stone, J.H. and Weyand, CM., eds, Systemic lupus erythematosus B. Clinical and Laboratory features Primer on the Rheumatic Diseases, 12th ed. (Arthritis Foundation, Atlanta, GA) pp 335–346.
  • Tan, EM., Feltkamp, T.E.W., Smolen, J.S., Butcher, B., Dawkins, R., Fritzler, M.J., et al. (1997) "Range of antinuclear antibodies in "healthy" individuals", Arthritis Rheum. 40, 1601–1611.
  • Kavanaugh, A.F. and Solomon, D.H. and The American College of Rheumatology Ad Hoc Committee on immunologic testing guidelines (2002) "Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests", Arthritis Rheum. 47, 546–555.
  • Burlingame, R.W. and Cervera, R. (2002) "Anti-chromatin (anti-nucleosome) autoantibodies", Autoimmun. Rev. 1, 321–328.
  • Simon, J.A., Cabiedes, J., Ortiz, E., Alcocer-Varela, J. and Sanchez-Guerrero, J. (2003) "Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker", Rheumatology 43, 220–224.
  • McClain, UT., Ramsland, RA., Kaufman, KM. and James, LA. (2002) "Anti-Sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens", J. Immunol. 168, 2054–2062.
  • Phan, T.G., Wong, R.C. and Adelstein, S. (2002) "Autoantibodies to extractable nuclear antigens: making detection and interpretation more meaningful", Clin. Diagn. Lab. Immunol. 9, 1–7.
  • Isenberg, D.A., Garton, M., Reichlin, M.W. and Reichlin, M. (1997) "Long-term follow-up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients", Br. J. Rheumatol. 36, 229–233.
  • Reichlin, M. (2000) "ANA negative systemic lupus erythematosus sera revisited serologically", Lupus. 9, 116–119.
  • Sanchez-Guerrero, J., Lew, R.A., Fossel, AR and Schur, PH. (1996) "Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus", Arthritis Rheum. 39, 1055–1061.
  • Roubey, R. (1996) "Review: immunology of the antiphospholipid antibody syndrome", Arthritis Rheum. 39, 1444–1454.
  • Greaves, M., Cohen, H., Machin, S.J. and Mackie, I. (2000) "Guidelines on the investigation and management of the anti-phospholipid syndrome", Br J. Haematol. 109, 704–715.
  • Love, RE. and Santoro, S.A. (1990) "Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance", Ann. Int. Med. 112, 682–698.
  • Dijkstra, S., Nieuwenhuys, E.J. and Swaak, A.J. (1999) "The prognosis and outcome of patients referred to an outpatient clinic for rheumatic diseases characterized by the presence of antinuclear antibodies (ANA)", Scand. J. Rheumatol. 28, 33–37.
  • Arbuckle, MR., James, J.A., Kohlhase, K.F., Rubartone, MX, Dennis, G.J. and Harley, J.B. (2001) "Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus", Scand. J. Immunol. 54, 211–219.
  • Arbuckle, MR., McClain, UT., Rubertone, UV, Scofield, R.H., Dennis, G.J., James, LA., et al. (2003) "Development of autoantibodies before the clinical onset of systemic lupus erythematosus", N. EngL J. Med. 349, 1526–1533.
  • Ravirajan, CT., Rowse, L., MacGowan, J.R. and Isenberg, D.A. (2001) "An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study", Rheumatology 40, 1405–1412.
  • Salomonsson, S., Dorner, T., Theander, E., Bremme, K., Larsson, P. and Wahren-Herlenius, M. (2002) "A serologic marker for fetal risk of congenital heart block", Arthritis Rheum. 46, 1233–1241.
  • Hassan, A.B., Lundberg, I.E., Isenberg, D. and Wahren-Herlenius, M. (2002) "Serial analysis of Ro/SSA and La/SSB antibody levels and correlation with clinical disease activity in patients with systemic lupus erythematosus", Scand. J. Rheumatol. 31, 133–139.
  • Cortes-Hemandez, J., Ordi-Ros, J., Paredes, F., Casellas, M., Castillo, F. and Vilardell-Tarres, M. (2002) "Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies", Rheumatology 41,643–650.
  • Isshi, K. and Hirohata, S. (1996) "Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythe-matosus", Arthritis Rheum. 39, 1483–1490.
  • Robinson, W.H., Lawrence, S. and Utz, P. (2002) "Proteomics technologies for the study of autoimmune disease", Arthritis Rheum. 46, 885–893.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.